A study on dexmethasone as an adjuvant to 0.2% Ropivacaine in USG guided preemptive caudal epidural block for peri operative analgesia in patients undergoing lumbar spine surgeries

A Comparative study on Dexamethasone as an adjuvant to 0.2% Ropivacaine in USG Guided Pre-Emptive Caudal Epidural block for perioperative analgesia in patients undergoing degenerative lumbar spine surgeries

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/09/045813

Enrollment

Registered

2022-09-23

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 3- Administration Health Condition 2: 3- Administration Health Condition 3: 3- Administration

Interventions

Intervention1: Inj Ropivacaine: Single shot Inj Ropivacaine 0.2% used for adult caudal epidural block Control Intervention1: Caudal epidural block in patients undergoing degenerative lumbar spine surg

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients belonging to ASA I,II. 2. Patients who give informed written consent.

Exclusion criteria

Exclusion criteria: 1.Patients refusal for study, patients who underwent a previous lumbar spine surgery 2. Patients with a contraindication to regional anaesthesia 3. Patients with hypersensitivity to ropivacaine. 4. Patients with known cardiac, renal, hepatic, neurological disorders that would interfere with cardiovascular response assessment. 5. Patients with spine abnormalities and body dysmorphism. 6. Patients with coagulopathy or on any anti coagulants. 7. Use of benzodiazepines, anticonvulsants, alcohol, opioids or other psychotropic drugs.

Design outcomes

Primary

Measure	Time frame
To compare intraoperative opioid consumption To compare duration of analgesiaTimepoint: 6-48hrs	—

Secondary

Measure	Time frame
To compare the hemodynamic changes To compare adverse effectsTimepoint: 6-48hrs	—

Countries

India

Contacts

Public ContactDr Sitara A Y

Vydehi institute of medical sciences and research centre

drsitaraay@gmail.com9902096666

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026